Chemoaffinity capture of pre-targeted prostate cancer cells with magnetic beads

Prostate

Volumn 72, Issue 14, 2012, Pages 1532-1541

  Wu, Lisa Y ^a   Liu, Tiancheng ^a   Hopkins, Mark R ^a   Davis, William C ^a   Berkman, Clifford E ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Cancer Targeted Technology   (United States)

Author keywords

circulating tumor cells; flow cytometry; magnetic bead; prostate cancer; prostate specific membrane antigen; PSMA

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; BIOTIN; CTT 54; MACROGOL; PROSTATE SPECIFIC MEMBRANE ANTIGEN; STREPTAVIDIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER DIAGNOSIS; CELL ISOLATION; CELL VIABILITY; CIRCULATING TUMOR CELL; CONTROLLED STUDY; IN VITRO STUDY; LEUKOCYTE; MAGNETIC BEAD; MEDICAL DEVICE; METASTASIS; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIGENS, SURFACE; CELL LINE, TUMOR; FLOW CYTOMETRY; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; IMMUNOMAGNETIC SEPARATION; MALE; NEOPLASMS, HORMONE-DEPENDENT; NEOPLASTIC CELLS, CIRCULATING; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865500707     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22508     Document Type: Article

References (40)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60 (5): 277-300.
2. Vessella PHLRL,. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone. Cancer Metastasis Rev 1999; 17 (4): 331-336.
3. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CC, Mulder E, Boersma W, Trapman J,., Androgen receptors in endocrine-therapy- resistant human prostate cancer. Int J Cancer 1991; 48 (2): 189-193.
4. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW,. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10 (20): 6897-6904. (Pubitemid 39383039)
5. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF,. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351 (8): 781-791. (Pubitemid 39095313)
6. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW,. Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005; 23 (7): 1420-1430.
7. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV, Terstappen LW,. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 2006; 12 (14 Pt 1): 4218-4224.
8. Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LW, Hayes DF,. Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006; 12 (21): 6403-6409. (Pubitemid 44799711)
9. Shaffer DR, Leversha MA, Danila DC, Lin O, Gonzalez-Espinoza R, Gu B, Anand A, Smith K, Maslak P, Doyle GV, Terstappen LW, Lilja H, Heller G, Fleisher M, Scher HI,. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 2007; 13 (7): 2023-2029. (Pubitemid 46649868)
10. Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, Lilja H, Schwartz L, Larson S, Fleisher M, Scher HI,. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007; 13 (23): 7053-7058. (Pubitemid 350276887)
11. Chen BT, Loberg RD, Neeley CK, O'Hara SM, Gross S, Doyle G, Dunn RL, Kalikin LM, Pienta KJ,. Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease. Urology 2005; 65 (3): 616-621. (Pubitemid 40386036)
12. Makarovskiy AN, Ackerley W III, Wojcik L, Halpert GK, Stein BS, Carreiro MP, Hixson DC,. Application of immunomagnetic beads in combination with RT-PCR for the detection of circulating prostate cancer cells. J Clin Lab Anal 1997; 11 (6): 346-350. (Pubitemid 27513668)
13. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, Martens JW, Gratama JW, Sleijfer S, Foekens JA,. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009; 101 (1): 61-66.
14. Thiery JP,. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2 (6): 442-454.
15. Bacich DJ, Pinto JT, Tong WP, Heston WD,. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase. Mamm Genome 2001; 12 (2): 117-123. (Pubitemid 32147666)
16. Mannweiler S, Amersdorfer P, Trajanoski S, Terrett JA, King D, Mehes G,. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res 2009; 15 (2): 167-172.
17. Tang H, Brown M, Ye Y, Huang G, Zhang Y, Wang Y, Zhai H, Chen X, Shen TY, Tenniswood M,. Prostate targeting ligands based on N-acetylated alpha-linked acidic dipeptidase. Biochem Biophys Res Commun 2003; 307 (1): 8-14. (Pubitemid 36808529)
18. Foss CA, Mease RC, Fan H, Wang Y, Ravert HT, Dannals RF, Olszewski RT, Heston WD, Kozikowski AP, Pomper MG,. Radiolabeled small-molecule ligands for prostate-specific membrane antigen: In vivo imaging in experimental models of prostate cancer. Clin Cancer Res 2005; 11 (11): 4022-4028. (Pubitemid 40791565)
19. Guilarte TR, McGlothan JL, Foss CA, Zhou J, Heston WD, Kozikowski AP, Pomper MG,. Glutamate carboxypeptidase II levels in rodent brain using [125I]DCIT quantitative autoradiography. Neurosci Lett 2005; 387 (3): 141-144. (Pubitemid 41160545)
20. Pomper MG, Musachio JL, Zhang J, Scheffel U, Zhou Y, Hilton J, Maini A, Dannals RF, Wong DF, Kozikowski AP,. 11C-MCG: Synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase). Mol Imaging 2002; 1 (2): 96-101.
21. Wu LY, Liu T, Grimm AL, Davis WC, Berkman CE,. Flow cytometric detection of prostate tumor cells using chemoaffinity labels. Prostate 2011; 71 (1): 52-61.
22. Wu LY, Anderson MO, Toriyabe Y, Maung J, Campbell TY, Tajon C, Kazak M, Moser J, Berkman CE,. The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen. Bioorg Med Chem 2007; 15 (23): 7434-7443. (Pubitemid 47539133)
23. Wu LY, Do JC, Kazak M, Page H, Toriyabe Y, Anderson MO, Berkman CE,. Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen. Bioorg Med Chem Lett 2008; 18 (1): 281-284.
24. Maung J, Mallari JP, Girtsman TA, Wu LY, Rowley JA, Santiago NM, Brunelle AN, Berkman CE,. Probing for a hydrophobic a binding register in prostate-specific membrane antigen with phenylalkylphosphonamidates. Bioorg Med Chem 2004; 12 (18): 4969-4979. (Pubitemid 39164405)
25. Anderson MO, Wu LY, Santiago NM, Moser JM, Rowley JA, Bolstad ES, Berkman CE,. Substrate specificity of prostate-specific membrane antigen. Bioorg Med Chem 2007; 15 (21): 6678-6686. (Pubitemid 47385247)
26. Carter RE, Feldman AR, Coyle JT,. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci USA 1996; 93 (2): 749-753. (Pubitemid 26041162)
27. Vuckovic S, Gardiner D, Field K, Chapman GV, Khalil D, Gill D, Marlton P, Taylor K, Wright S, Pinzon-Charry A, Pyke CM, Rodwell R, Hockey RL, Gleeson M, Tepes S, True D, Cotterill A, Hart DN,. Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay. J Immunol Methods 2004; 284 (1-2): 73-87. (Pubitemid 38084915)
28. Perruche S, Kleinclauss F, Lienard A, Robinet E, Tiberghien P, Saas P,. A single-platform approach using flow cytometry and microbeads to evaluate immune reconstitution in mice after bone marrow transplantation. J Immunol Methods 2004; 294 (1-2): 53-66. (Pubitemid 39626591)
29. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP,. LNCaP model of human prostatic carcinoma. Cancer Res 1983; 43 (4): 1809-1818. (Pubitemid 13122588)
30. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW,. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17 (1): 16-23. (Pubitemid 9239413)
31. Riccardi C, Nicoletti I,. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006; 1 (3): 1458-1461.
32. Myllyl̈a MKaR,. Effect of glucose on photoacoustic signals at the wavelengths of 1064 and 532 nm in pig blood and intralipid. J Phys D: Appl Phys 2005; 38: 8.
33. Roggan A FM, Dörschel K, Hahn A, Müller G,., Optical properties of circulating human blood in the wavelength range 400-2500 nm. J Biomed Opt 1999; 4: 11.
34. Jain NC,. Schalm's Veterinary Hematology, 4th edition. Philadelphia: Lea & Febiger; 1986.
35. Swenson MJ,. Dukes's Physiology of Domestic Animals, 8th edition. Ithaca and London: Cornell Univesity Press; 1970.
36. Liu T, Wu LY, Kazak M, Berkman CE,. Cell-Surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen. Prostate 2008; 68 (9): 955-964. (Pubitemid 351794160)
37. Liu T, Toriyabe Y, Kazak M, Berkman CE,. Pseudoirreversible inhibition of prostate-specific membrane antigen by phosphoramidate peptidomimetics. Biochemistry 2008; 47: 12658-12660.
38. Guilarte TR, McGlothan JL, Foss CA, Zhou J, Heston WD, Kozikowski AP, Pomper MG,. Department of environmental health sciences JHSoPHBMDUSA. Glutamate carboxypeptidase II levels in rodent brain using [125I]DCIT quantitative autoradiography. Neurosci Lett 2005; 387 (3): 141-144. (Pubitemid 41160545)
39. Alon R, Bayer EA, Wilchek M,. Streptavidin contains an RYD sequence which mimics the RGD receptor domain of fibronectin. Biochem Biophys Res Commun 1990; 170 (3): 1236-1241. (Pubitemid 20273401)
40. Kolostova K, Pinterova D, Hoffman RM, Bobek V,. Circulating human prostate cancer cells from an orthotopic mouse model rapidly captured by immunomagnetic beads and imaged by GFP expression. Anticancer Res 2011; 31 (5): 1535-1539.